Clinical Programs Update

Inside Stanford Digestive Health - Autumn 2026

Bringing Ultrasound to the Bedside - POCUS in Hepatology

One scan. Real-time answers. Discover how Stanford Health Care is bringing liver point-of-care ultrasound (POCUS) into routine hepatology care.

This video introduces a focused bedside scan that extends the physical exam and complements formal radiology. Learn how Stanford’s liver POCUS program assesses liver fat and stiffness, volume status in cirrhosis, and signs of portal hypertension—all in about 10 minutes per scan.

Explore the program’s findings, how the team built its training and clinical workflow, and what this approach means for patients: staging and counseling in one visit, with ongoing monitoring to support treatment decisions.

For referring clinicians:
• Submit referrals electronically through PRISM.
• Fax referral forms to (650) 320-9443.
• For POCUS questions, contact gougola@stanford.edu.

Learn more: Stanford Digestive Health Center

#POCUS #LiverHealth #StanfordHealthCare

Introducing ALTO: Advanced Liver Tumor and Transplant Oncology

Stanford GI is pleased to introduce ALTO — Advanced Liver Tumor and Transplant Oncology, a new multidisciplinary clinic for patients with primary or metastatic liver tumors, including those being evaluated for transplant oncology candidacy. The clinic is spearheaded by Dr. Dhanasekaran, Director of Stanford's Liver Mass Clinic; Dr. Daugherty, Medical Director of Liver Transplant; Dr. Heestand of GI Oncology; and Dr. Visser and Dr. Sasaki of Hepatobiliary and Transplant Surgery.

Historically, these patients have needed separate visits with hepatology, oncology, surgery, and interventional radiology (IR) — often spread over several weeks — before a treatment plan could be finalized. The ALTO clinic brings all four specialties together in one visit, so decisions are made in real time rather than sequentially. Patients leave with a single, coordinated plan instead of a string of redundant appointments, and the clinic serves as the implementation arm of the liver tumor board, ensuring board recommendations are acted on promptly rather than simply documented.

Who Needs to Be Seen in the Multidisciplinary Clinic (MDC)?

Patients with complex decision points — around treatment sequencing, transplant candidacy, or multimodal therapy — should be referred directly to the ALTO Clinic:

-       Advanced HCC: tumors beyond traditional transplant criteria (e.g., beyond UNOS downstaging criteria) where downstaging, systemic therapy, or Loco-regional therapy (LRT) is being considered, and newly diagnosed multifocal or macrovascular invasive disease.

-       Cholangiocarcinoma (intrahepatic or perihilar): candidates for neoadjuvant therapy or transplant, or cases requiring coordination of systemic therapy, LRT, and surgical timing.

-       Colorectal liver metastases: transplant candidates under clinical or protocol-based indications, and complex or borderline resectable cases weighing LRT vs. resection vs. transplant.

-       Neuroendocrine liver metastases: patients being considered for transplant, embolization, or systemic therapy integration.

-       Any patient with advanced liver tumors being considered for transplant.

For Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

On This Page

In This Issue

Autumn 2026